iSpecimen Inc reports results for the quarter ended in March - Earnings Summary

iSpecimen

04/05/2023 14:33

* iSpecimen Inc  ISPC.OQ  reported a quarterly adjusted loss
of 27
cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 32 cents per
share.
    * Revenue rose 17.1% to $2.95 million from a year ago;
analysts
expected $2.62 million. 
    * iSpecimen Inc's reported EPS for the quarter was a loss
of 27
cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * iSpecimen Inc shares had risen by 29.9% this quarter and
gained 26.5% so far this year.
    * The company reported a quarterly loss of $2.43 million.
    * Wall Street's median 12-month price target for iSpecimen
Inc is
$6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
4 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.32          -0.27          Beat
 Dec. 31 2022      -0.37          -0.24          Beat
 Sep. 30 2022      -0.34          -0.35          Missed
 Jun. 30 2022      -0.27          -0.30          Missed